Novartis International AG http://www.novartis.com Novartis receives approval in Switzerland for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine 2009-11-13T16:41:22 CET http://www.novartis.com/newsroom/media-releases/en/2009/1355007.shtml Novartis launches Prevacid®24HR over-the-counter for full 24-hour frequent heartburn treatment 2009-11-12T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1354451.shtml Novartis receives regulatory approval in Germany for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine 2009-11-05T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1352736.shtml Novartis to expand its human vaccines presence in China through proposed acquisition of a majority stake in Zhejiang Tianyuan 2009-11-04T07:00:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1352376.shtml Novartis announces USD 1 billion investment to build largest pharmaceutical R&D institute in China 2009-11-03T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1352116.shtml Novartis on track to deliver Influenza A (H1N1) vaccine for the US 2009-10-29T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1351038.shtml Novartis biological drug Ilaris® approved in EU to treat children and adults with CAPS, a rare debilitating auto-inflammatory disease 2009-10-28T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1350596.shtml Novartis receives approval in the European Union for Exforge HCT®, a new 3-in-1 treatment for high blood pressure 2009-10-23T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1349636.shtml Novartis delivers strong new product momentum and operational performance in first nine months of 2009 2009-10-22T06:59:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1349248.shtml New Phase II data show ACZ885 gave better pain relief and flare prevention for patients with chronic gout than an injectable corticosteroid 2009-10-20T07:15:00 CET http://www.novartis.com/newsroom/media-releases/en/2009/1348439.shtml